- Palbociclib is white to beige powder.
- Palbociclib is a CDK4/6 inhibitor that can selectively inhibit cyclin-dependent kinase 4 and 6 (CDK4/6), restore cell cycle control, and block tumor cell proliferation.
- Palbociclib can double the progression-free survival of breast cancer compared with letrozole.
[ Disclaimer: The APIs are used for production of drug products. DO NOT USE DIRECTLY FOR PATIENTS. ]
No. 263, Jianning Road, Gulou District, Nanjing, Jiangsu, 210000, China